{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T00:42:27Z","timestamp":1792024947717,"version":"4.4.0"},"reference-count":74,"publisher":"Springer Science and Business Media LLC","issue":"38","license":[{"start":{"date-parts":[[2017,5,22]],"date-time":"2017-05-22T00:00:00Z","timestamp":1495411200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2017,5,22]],"date-time":"2017-05-22T00:00:00Z","timestamp":1495411200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Oncogene"],"published-print":{"date-parts":[[2017,9,21]]},"DOI":"10.1038\/onc.2017.139","type":"journal-article","created":{"date-parts":[[2017,5,23]],"date-time":"2017-05-23T05:13:20Z","timestamp":1495516400000},"page":"5407-5420","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":31,"title":["A viral microRNA downregulates metastasis suppressor CD82 and induces cell invasion and angiogenesis by activating the c-Met signaling"],"prefix":"10.1038","volume":"36","author":[{"given":"W","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y","family":"Shang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Q","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B J","family":"Krueger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"Renne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S-J","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,5,22]]},"reference":[{"key":"BFonc2017139_CR1","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1038\/nrc2888","volume":"10","author":"EA Mesri","year":"2010","unstructured":"Mesri EA, Cesarman E, Boshoff C . Kaposi's sarcoma and its associated herpesvirus. Nat Rev Cancer 2010; 10: 707\u2013719.","journal-title":"Nat Rev Cancer"},{"key":"BFonc2017139_CR2","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1128\/MMBR.67.2.175-212.2003","volume":"67","author":"LA Dourmishev","year":"2003","unstructured":"Dourmishev LA, Dourmishev AL, Palmeri D, Schwartz RA, Lukac DM . Molecular genetics of Kaposi's sarcoma-associated herpesvirus (human herpesvirus-8) epidemiology and pathogenesis. Microbiol Mol Biol Rev 2003; 67: 175\u2013212, table of contents.","journal-title":"Microbiol Mol Biol Rev"},{"key":"BFonc2017139_CR3","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1081\/CNV-200032788","volume":"22","author":"TW Cheung","year":"2004","unstructured":"Cheung TW . AIDS-related cancer in the era of highly active antiretroviral therapy (HAART): a model of the interplay of the immune system, virus, and cancer. 'On the offensive\u2014the Trojan Horse is being destroyed'\u2013part A: Kaposi's sarcoma. Cancer Invest 2004; 22: 774\u2013786.","journal-title":"Cancer Invest"},{"key":"BFonc2017139_CR4","doi-asserted-by":"publisher","first-page":"3342","DOI":"10.1128\/JVI.02052-08","volume":"83","author":"S Sadagopan","year":"2009","unstructured":"Sadagopan S, Sharma-Walia N, Veettil MV, Bottero V, Levine R, Vart RJ et al. Kaposi's sarcoma-associated herpesvirus upregulates angiogenin during infection of human dermal microvascular endothelial cells, which induces 45\u2009S rRNA synthesis, antiapoptosis, cell proliferation, migration, and angiogenesis. J Virol 2009; 83: 3342\u20133364.","journal-title":"J Virol"},{"key":"BFonc2017139_CR5","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1111\/j.1600-065X.1992.tb01412.x","volume":"127","author":"B Ensoli","year":"1992","unstructured":"Ensoli B, Barillari G, Gallo RC . Cytokines and growth factors in the pathogenesis of AIDS-associated Kaposi's sarcoma. Immunol Rev 1992; 127: 147\u2013155.","journal-title":"Immunol Rev"},{"key":"BFonc2017139_CR6","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1111\/j.1600-0560.2006.00567.x","volume":"33","author":"L Pantanowitz","year":"2006","unstructured":"Pantanowitz L, Dezube BJ, Hernandez-Barrantes S, Tahan SR, Dabbous MK . Matrix metalloproteinases in the progression and regression of Kaposi's sarcoma. J Cutan Pathol 2006; 33: 793\u2013798.","journal-title":"J Cutan Pathol"},{"key":"BFonc2017139_CR7","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1016\/S0002-9440(10)63702-9","volume":"163","author":"L Rosano","year":"2003","unstructured":"Rosano L, Spinella F, Di Castro V, Nicotra MR, Albini A, Natali PG et al. Endothelin receptor blockade inhibits molecular effectors of Kaposi's sarcoma cell invasion and tumor growth in vivo. Am J Pathol 2003; 163: 753\u2013762.","journal-title":"Am J Pathol"},{"key":"BFonc2017139_CR8","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1097\/00042560-199807010-00002","volume":"18","author":"D Blankaert","year":"1998","unstructured":"Blankaert D, Simonart T, Van Vooren JP, Parent D, Liesnard C, Farber CM et al. Constitutive release of metalloproteinase-9 (92-kd type IV collagenase) by Kaposi's sarcoma cells. J Acquir Immune Defic Syndr Hum Retrovirol 1998; 18: 203\u2013209.","journal-title":"J Acquir Immune Defic Syndr Hum Retrovirol"},{"key":"BFonc2017139_CR9","doi-asserted-by":"publisher","first-page":"1881","DOI":"10.1101\/gad.17352611","volume":"25","author":"BR Cullen","year":"2011","unstructured":"Cullen BR . Viruses and microRNAs: RISCy interactions with serious consequences. Genes Dev 2011; 25: 1881\u20131894.","journal-title":"Genes Dev"},{"key":"BFonc2017139_CR10","doi-asserted-by":"publisher","first-page":"5570","DOI":"10.1073\/pnas.0408192102","volume":"102","author":"X Cai","year":"2005","unstructured":"Cai X, Lu S, Zhang Z, Gonzalez CM, Damania B, Cullen BR . Kaposi's sarcoma-associated herpesvirus expresses an array of viral microRNAs in latently infected cells. Proc Natl Acad Sci USA 2005; 102: 5570\u20135575.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFonc2017139_CR11","doi-asserted-by":"publisher","first-page":"9301","DOI":"10.1128\/JVI.79.14.9301-9305.2005","volume":"79","author":"MA Samols","year":"2005","unstructured":"Samols MA, Hu J, Skalsky RL, Renne R . Cloning and identification of a microRNA cluster within the latency-associated region of Kaposi's sarcoma-associated herpesvirus. J Virol 2005; 79: 9301\u20139305.","journal-title":"J Virol"},{"key":"BFonc2017139_CR12","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1261\/rna.2326106","volume":"12","author":"A Grundhoff","year":"2006","unstructured":"Grundhoff A, Sullivan CS, Ganem D . A combined computational and microarray-based approach identifies novel microRNAs encoded by human gamma-herpesviruses. RNA 2006; 12: 733\u2013750.","journal-title":"RNA"},{"key":"BFonc2017139_CR13","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1086\/511434","volume":"195","author":"V Marshall","year":"2007","unstructured":"Marshall V, Parks T, Bagni R, Wang CD, Samols MA, Hu J et al. Conservation of virally encoded microRNAs in Kaposi sarcoma\u2014associated herpesvirus in primary effusion lymphoma cell lines and in patients with Kaposi sarcoma or multicentric Castleman disease. J Infect Dis 2007; 195: 645\u2013659.","journal-title":"J Infect Dis"},{"key":"BFonc2017139_CR14","doi-asserted-by":"publisher","first-page":"e1000389","DOI":"10.1371\/journal.ppat.1000389","volume":"5","author":"AJ O'Hara","year":"2009","unstructured":"O'Hara AJ, Chugh P, Wang L, Netto EM, Luz E, Harrington WJ et al. Pre-micro RNA signatures delineate stages of endothelial cell transformation in Kaposi sarcoma. PLoS Pathog 2009; 5: e1000389.","journal-title":"PLoS Pathog"},{"key":"BFonc2017139_CR15","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/S0092-8674(04)00045-5","volume":"116","author":"DP Bartel","year":"2004","unstructured":"Bartel DP . MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004; 116: 281\u2013297.","journal-title":"Cell"},{"issue":"8","key":"BFonc2017139_CR16","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1016\/j.tim.2017.02.002","volume":"25","author":"Jie Qin","year":"2017","unstructured":"Qin J, Li W, Gao SJ, Lu C. KSHV microRNAs: Tricks of the Devil. Trends Microbiol 2017; e-pub ahead of print 2 March 2017 doi:10.1016\/j.tim.2017.02.002.","journal-title":"Trends in Microbiology"},{"key":"BFonc2017139_CR17","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1016\/j.chom.2009.11.008","volume":"6","author":"P Bellare","year":"2009","unstructured":"Bellare P, Ganem D . Regulation of KSHV lytic switch protein expression by a virus-encoded microRNA: an evolutionary adaptation that fine-tunes lytic reactivation. Cell Host Microbe 2009; 6: 570\u2013575.","journal-title":"Cell Host Microbe"},{"key":"BFonc2017139_CR18","doi-asserted-by":"publisher","first-page":"2697","DOI":"10.1128\/JVI.01997-09","volume":"84","author":"F Lu","year":"2010","unstructured":"Lu F, Stedman W, Yousef M, Renne R, Lieberman PM . Epigenetic regulation of Kaposi's sarcoma-associated herpesvirus latency by virus-encoded microRNAs that target Rta and the cellular Rbl2-DNMT pathway. J Virol 2010; 84: 2697\u20132706.","journal-title":"J Virol"},{"key":"BFonc2017139_CR19","doi-asserted-by":"publisher","first-page":"e16224","DOI":"10.1371\/journal.pone.0016224","volume":"6","author":"X Lin","year":"2011","unstructured":"Lin X, Liang D, He Z, Deng Q, Robertson ES, Lan K . miR-K12-7-5p encoded by Kaposi's sarcoma-associated herpesvirus stabilizes the latent state by targeting viral ORF50\/RTA. PLoS One 2011; 6: e16224.","journal-title":"PLoS One"},{"key":"BFonc2017139_CR20","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1038\/embor.2010.132","volume":"11","author":"CC Lu","year":"2010","unstructured":"Lu CC, Li Z, Chu CY, Feng J, Feng J, Sun R et al. MicroRNAs encoded by Kaposi's sarcoma-associated herpesvirus regulate viral life cycle. EMBO Rep 2010; 11: 784\u2013790.","journal-title":"EMBO Rep"},{"key":"BFonc2017139_CR21","doi-asserted-by":"publisher","first-page":"11698","DOI":"10.1128\/JVI.06855-11","volume":"86","author":"X Lei","year":"2012","unstructured":"Lei X, Zhu Y, Jones T, Bai Z, Huang Y, Gao SJ . A Kaposi's sarcoma-associated herpesvirus microRNA and its variants target the transforming growth factor beta pathway to promote cell survival. J Virol 2012; 86: 11698\u201311711.","journal-title":"J Virol"},{"key":"BFonc2017139_CR22","doi-asserted-by":"publisher","first-page":"11663","DOI":"10.1128\/JVI.01147-12","volume":"86","author":"JR Abend","year":"2012","unstructured":"Abend JR, Ramalingam D, Kieffer-Kwon P, Uldrick TS, Yarchoan R, Ziegelbauer JM . Kaposi's sarcoma-associated herpesvirus microRNAs target IRAK1 and MYD88, two components of the toll-like receptor\/interleukin-1\u2009R signaling cascade, to reduce inflammatory-cytokine expression. J Virol 2012; 86: 11663\u201311674.","journal-title":"J Virol"},{"key":"BFonc2017139_CR23","doi-asserted-by":"publisher","first-page":"e1000742","DOI":"10.1371\/journal.ppat.1000742","volume":"6","author":"Z Qin","year":"2010","unstructured":"Qin Z, Freitas E, Sullivan R, Mohan S, Bacelieri R, Branch D et al. Upregulation of xCT by KSHV-encoded microRNAs facilitates KSHV dissemination and persistence in an environment of oxidative stress. PLoS Pathog 2010; 6: e1000742.","journal-title":"PLoS Pathog"},{"key":"BFonc2017139_CR24","doi-asserted-by":"publisher","first-page":"603961","DOI":"10.1155\/2012\/603961","volume":"2012","author":"Z Qin","year":"2012","unstructured":"Qin Z, Jakymiw A, Findlay V, Parsons C . KSHV-encoded microRNAs: lessons for viral cancer pathogenesis and emerging concepts. Int J Cell Biol 2012; 2012: 603961.","journal-title":"Int J Cell Biol"},{"key":"BFonc2017139_CR25","doi-asserted-by":"publisher","first-page":"e1005171","DOI":"10.1371\/journal.ppat.1005171","volume":"11","author":"M Hu","year":"2015","unstructured":"Hu M, Wang C, Li W, Lu W, Bai Z, Qin D et al. A KSHV microRNA directly targets G protein-coupled receptor kinase 2 to promote the migration and invasion of endothelial cells by inducing CXCR2 and activating AKT signaling. PLoS Pathog 2015; 11: e1005171.","journal-title":"PLoS Pathog"},{"key":"BFonc2017139_CR26","doi-asserted-by":"crossref","first-page":"32286","DOI":"10.18632\/oncotarget.8591","volume":"7","author":"W Li","year":"2016","unstructured":"Li W, Jia X, Shen C, Zhang M, Xu J, Shang Y et al. A KSHV microRNA enhances viral latency and induces angiogenesis by targeting GRK2 to activate the CXCR2\/AKT pathway. Oncotarget 2016; 7: 32286\u201332305.","journal-title":"Oncotarget"},{"key":"BFonc2017139_CR27","doi-asserted-by":"publisher","first-page":"e1005605","DOI":"10.1371\/journal.ppat.1005605","volume":"12","author":"W Li","year":"2016","unstructured":"Li W, Yan Q, Ding X, Shen C, Hu M, Zhu Y et al. The SH3BGR\/STAT3 pathway regulates cell migration and angiogenesis induced by a gammaherpesvirus microRNA. PLoS Pathog 2016; 12: e1005605.","journal-title":"PLoS Pathog"},{"key":"BFonc2017139_CR28","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1038\/nrc2543","volume":"9","author":"M Zoller","year":"2009","unstructured":"Zoller M . Tetraspanins: push and pull in suppressing and promoting metastasis. Nat Rev Cancer 2009; 9: 40\u201355.","journal-title":"Nat Rev Cancer"},{"key":"BFonc2017139_CR29","first-page":"5284","volume":"61","author":"X Yang","year":"2001","unstructured":"Yang X, Wei LL, Tang C, Slack R, Mueller S, Lippman ME . Overexpression of KAI1 suppresses in vitro invasiveness and in vivo metastasis in breast cancer cells. Cancer Res 2001; 61: 5284\u20135288.","journal-title":"Cancer Res"},{"key":"BFonc2017139_CR30","doi-asserted-by":"publisher","first-page":"2006","DOI":"10.1002\/ijc.27904","volume":"132","author":"C Nishioka","year":"2013","unstructured":"Nishioka C, Ikezoe T, Furihata M, Yang J, Serada S, Naka T et al. CD34(+)\/CD38(\u2212) acute myelogenous leukemia cells aberrantly express CD82 which regulates adhesion and survival of leukemia stem cells. Int J Cancer 2013; 132: 2006\u20132019.","journal-title":"Int J Cancer"},{"key":"BFonc2017139_CR31","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.canlet.2005.08.018","volume":"240","author":"WM Liu","year":"2006","unstructured":"Liu WM, Zhang XA . KAI1\/CD82, a tumor metastasis suppressor. Cancer Lett 2006; 240: 183\u2013194.","journal-title":"Cancer Lett"},{"key":"BFonc2017139_CR32","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1016\/j.molmed.2005.10.002","volume":"11","author":"H Tonoli","year":"2005","unstructured":"Tonoli H, Barrett JC . CD82 metastasis suppressor gene: a potential target for new therapeutics? Trends Mol Med 2005; 11: 563\u2013570.","journal-title":"Trends Mol Med"},{"key":"BFonc2017139_CR33","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.1161\/CIRCULATIONAHA.114.011096","volume":"130","author":"Q Wei","year":"2014","unstructured":"Wei Q, Zhang F, Richardson MM, Roy NH, Rodgers W, Liu Y et al. CD82 restrains pathological angiogenesis by altering lipid raft clustering and CD44 trafficking in endothelial cells. Circulation 2014; 130: 1493\u20131504.","journal-title":"Circulation"},{"key":"BFonc2017139_CR34","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1038\/nm1444","volume":"12","author":"S Bandyopadhyay","year":"2006","unstructured":"Bandyopadhyay S, Zhan R, Chaudhuri A, Watabe M, Pai SK, Hirota S et al. Interaction of KAI1 on tumor cells with DARC on vascular endothelium leads to metastasis suppression. Nat Med 2006; 12: 933\u2013938.","journal-title":"Nat Med"},{"key":"BFonc2017139_CR35","doi-asserted-by":"publisher","first-page":"1759","DOI":"10.1016\/j.yexcr.2009.01.007","volume":"315","author":"Z Ruseva","year":"2009","unstructured":"Ruseva Z, Geiger PX, Hutzler P, Kotzsch M, Luber B, Schmitt M et al. Tumor suppressor KAI1 affects integrin alphavbeta3-mediated ovarian cancer cell adhesion, motility, and proliferation. Exp Cell Res 2009; 315: 1759\u20131771.","journal-title":"Exp Cell Res"},{"key":"BFonc2017139_CR36","first-page":"59","volume":"14","author":"XZ Guo","year":"2005","unstructured":"Guo XZ, Xu JH, Liu MP, Kleeff J, Ho CK, Ren LN et al. KAI1 inhibits anchorage-dependent and -independent pancreatic cancer cell growth. Oncol Rep 2005; 14: 59\u201363.","journal-title":"Oncol Rep"},{"key":"BFonc2017139_CR37","doi-asserted-by":"publisher","first-page":"1402","DOI":"10.1038\/sj.bjc.6605291","volume":"101","author":"V Zismanov","year":"2009","unstructured":"Zismanov V, Lishner M, Tartakover-Matalon S, Radnay J, Shapiro H, Drucker L . Tetraspanin-induced death of myeloma cell lines is autophagic and involves increased UPR signalling. Br J Cancer 2009; 101: 1402\u20131409.","journal-title":"Br J Cancer"},{"key":"BFonc2017139_CR38","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1096\/fj.06-6610com","volume":"21","author":"T Tohami","year":"2007","unstructured":"Tohami T, Drucker L, Shapiro H, Radnay J, Lishner M . Overexpression of tetraspanins affects multiple myeloma cell survival and invasive potential. FASEB J 2007; 21: 691\u2013699.","journal-title":"FASEB J"},{"key":"BFonc2017139_CR39","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1007\/s12253-013-9678-1","volume":"20","author":"AM Catrina Ene","year":"2014","unstructured":"Catrina Ene AM, Borze I, Guled M, Costache M, Leen G, Sajin M et al. MicroRNA expression profiles in Kaposi's sarcoma. Pathol Oncol Res 2014; 20: 153\u2013159.","journal-title":"Pathol Oncol Res"},{"key":"BFonc2017139_CR40","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1016\/j.chom.2011.09.012","volume":"10","author":"E Gottwein","year":"2011","unstructured":"Gottwein E, Corcoran DL, Mukherjee N, Skalsky RL, Hafner M, Nusbaum JD et al. Viral microRNA targetome of KSHV-infected primary effusion lymphoma cell lines. Cell Host Microbe 2011; 10: 515\u2013526.","journal-title":"Cell Host Microbe"},{"key":"BFonc2017139_CR41","doi-asserted-by":"publisher","first-page":"2367","DOI":"10.1038\/sj.onc.1209269","volume":"25","author":"SC Sridhar","year":"2006","unstructured":"Sridhar SC, Miranti CK . Tetraspanin KAI1\/CD82 suppresses invasion by inhibiting integrin-dependent crosstalk with c-Met receptor and Src kinases. Oncogene 2006; 25: 2367\u20132378.","journal-title":"Oncogene"},{"key":"BFonc2017139_CR42","doi-asserted-by":"publisher","first-page":"8123","DOI":"10.1074\/jbc.M611407200","volume":"282","author":"AR Todeschini","year":"2007","unstructured":"Todeschini AR, Dos Santos JN, Handa K, Hakomori SI . Ganglioside GM2-tetraspanin CD82 complex inhibits met and its cross-talk with integrins, providing a basis for control of cell motility through glycosynapse. J Biol Chem 2007; 282: 8123\u20138133.","journal-title":"J Biol Chem"},{"key":"BFonc2017139_CR43","doi-asserted-by":"publisher","first-page":"1919","DOI":"10.1002\/ijc.22887","volume":"121","author":"M Takahashi","year":"2007","unstructured":"Takahashi M, Sugiura T, Abe M, Ishii K, Shirasuna K . Regulation of c-Met signaling by the tetraspanin KAI-1\/CD82 affects cancer cell migration. Int J Cancer 2007; 121: 1919\u20131929.","journal-title":"Int J Cancer"},{"key":"BFonc2017139_CR44","doi-asserted-by":"publisher","first-page":"2821","DOI":"10.1182\/blood-2015-07-658823","volume":"126","author":"L Dai","year":"2015","unstructured":"Dai L, Trillo-Tinoco J, Cao Y, Bonstaff K, Doyle L, Del Valle L et al. Targeting HGF\/c-MET induces cell cycle arrest, DNA damage, and apoptosis for primary effusion lymphoma. Blood 2015; 126: 2821\u20132831.","journal-title":"Blood"},{"key":"BFonc2017139_CR45","doi-asserted-by":"publisher","first-page":"647","DOI":"10.2353\/ajpath.2009.080685","volume":"174","author":"R Bari","year":"2009","unstructured":"Bari R, Zhang YH, Zhang F, Wang NX, Stipp CS, Zheng JJ et al. Transmembrane interactions are needed for KAI1\/CD82-mediated suppression of cancer invasion and metastasis. Am J Pathol 2009; 174: 647\u2013660.","journal-title":"Am J Pathol"},{"key":"BFonc2017139_CR46","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1007\/s10555-015-9585-x","volume":"34","author":"J Feng","year":"2015","unstructured":"Feng J, Huang C, Wren JD, Wang DW, Yan J, Zhang J et al. Tetraspanin CD82: a suppressor of solid tumors and a modulator of membrane heterogeneity. Cancer Metastasis Rev 2015; 34: 619\u2013633.","journal-title":"Cancer Metastasis Rev"},{"key":"BFonc2017139_CR47","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0065-230X(09)03001-2","volume":"103","author":"JA Hanna","year":"2009","unstructured":"Hanna JA, Bordeaux J, Rimm DL, Agarwal S . The function, proteolytic processing, and histopathology of Met in cancer. Adv Cancer Res 2009; 103: 1\u201323.","journal-title":"Adv Cancer Res"},{"key":"BFonc2017139_CR48","doi-asserted-by":"publisher","first-page":"2310","DOI":"10.1245\/s10434-014-3553-5","volume":"21","author":"BS Koo","year":"2014","unstructured":"Koo BS, Kim JM, Seo ST, Yoon YH, Kwon KR, Kim SH et al. Upregulation of HGF and c-MET is associated with subclinical central lymph node metastasis in papillary thyroid microcarcinoma. Ann Surg Oncol 2014; 21: 2310\u20132317.","journal-title":"Ann Surg Oncol"},{"key":"BFonc2017139_CR49","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1007\/s10120-015-0471-6","volume":"19","author":"N Fuse","year":"2016","unstructured":"Fuse N, Kuboki Y, Kuwata T, Nishina T, Kadowaki S, Shinozaki E et al. Prognostic impact of HER2, EGFR, and c-MET status on overall survival of advanced gastric cancer patients. Gastric Cancer 2016; 19: 183\u2013191.","journal-title":"Gastric Cancer"},{"key":"BFonc2017139_CR50","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1111\/his.12691","volume":"67","author":"C Neuzillet","year":"2015","unstructured":"Neuzillet C, Couvelard A, Tijeras-Raballand A, de Mestier L, de Gramont A, Bedossa P et al. High c-Met expression in stage I-II pancreatic adenocarcinoma: proposal for an immunostaining scoring method and correlation with poor prognosis. Histopathology 2015; 67: 664\u2013676.","journal-title":"Histopathology"},{"key":"BFonc2017139_CR51","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1186\/s13000-015-0296-y","volume":"10","author":"S Yan","year":"2015","unstructured":"Yan S, Jiao X, Zou H, Li K . Prognostic significance of c-Met in breast cancer: a meta-analysis of 6010 cases. Diagn Pathol 2015; 10: 62.","journal-title":"Diagn Pathol"},{"key":"BFonc2017139_CR52","doi-asserted-by":"publisher","first-page":"1618","DOI":"10.3892\/ol.2014.2390","volume":"8","author":"Y Han","year":"2014","unstructured":"Han Y, Luo Y, Zhao J, Li M, Jiang Y . Overexpression of c-Met increases the tumor invasion of human prostate LNCaP cancer cells in vitro and in vitro. Oncol Lett 2014; 8: 1618\u20131624.","journal-title":"Oncol Lett"},{"key":"BFonc2017139_CR53","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.ygyno.2006.07.040","volume":"104","author":"C Leo","year":"2007","unstructured":"Leo C, Horn LC, Einenkel J, Hentschel B, Hockel M . Tumor hypoxia and expression of c-met in cervical cancer. Gynecol Oncol 2007; 104: 181\u2013185.","journal-title":"Gynecol Oncol"},{"key":"BFonc2017139_CR54","doi-asserted-by":"publisher","first-page":"2376","DOI":"10.1210\/jcem.87.5.8483","volume":"87","author":"S Yoshida","year":"2002","unstructured":"Yoshida S, Harada T, Iwabe T, Taniguchi F, Fujii A, Sakamoto Y et al. Induction of hepatocyte growth factor in stromal cells by tumor-derived basic fibroblast growth factor enhances growth and invasion of endometrial cancer. J Clin Endocrinol Metab 2002; 87: 2376\u20132383.","journal-title":"J Clin Endocrinol Metab"},{"key":"BFonc2017139_CR55","doi-asserted-by":"publisher","first-page":"2867","DOI":"10.1002\/j.1460-2075.1991.tb07836.x","volume":"10","author":"L Naldini","year":"1991","unstructured":"Naldini L, Weidner KM, Vigna E, Gaudino G, Bardelli A, Ponzetto C et al. Scatter factor and hepatocyte growth factor are indistinguishable ligands for the MET receptor. EMBO J 1991; 10: 2867\u20132878.","journal-title":"EMBO J"},{"key":"BFonc2017139_CR56","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1126\/science.1846706","volume":"251","author":"DP Bottaro","year":"1991","unstructured":"Bottaro DP, Rubin JS, Faletto DL, Chan AM, Kmiecik TE, Vande Woude GF et al. Identification of the hepatocyte growth factor receptor as the c-met proto-oncogene product. Science 1991; 251: 802\u2013804.","journal-title":"Science"},{"key":"BFonc2017139_CR57","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1038\/nrm1261","volume":"4","author":"C Birchmeier","year":"2003","unstructured":"Birchmeier C, Birchmeier W, Gherardi E, Vande Woude GF . Met, metastasis, motility and more. Nat Rev Mol Cell Biol 2003; 4: 915\u2013925.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"BFonc2017139_CR58","doi-asserted-by":"publisher","first-page":"2349","DOI":"10.1016\/j.biocel.2013.08.002","volume":"45","author":"Y Li","year":"2013","unstructured":"Li Y, Huang X, Zhang J, Li Y, Ma K . Synergistic inhibition of cell migration by tetraspanin CD82 and gangliosides occurs via the EGFR or cMet-activated Pl3K\/Akt signalling pathway. Int J Biochem Cell Biol 2013; 45: 2349\u20132358.","journal-title":"Int J Biochem Cell Biol"},{"key":"BFonc2017139_CR59","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1101\/gad.553410","volume":"24","author":"A Hansen","year":"2010","unstructured":"Hansen A, Henderson S, Lagos D, Nikitenko L, Coulter E, Roberts S et al. KSHV-encoded miRNAs target MAF to induce endothelial cell reprogramming. Genes Dev 2010; 24: 195\u2013205.","journal-title":"Genes Dev"},{"key":"BFonc2017139_CR60","doi-asserted-by":"publisher","first-page":"4249","DOI":"10.1128\/JVI.03687-14","volume":"89","author":"D Ramalingam","year":"2015","unstructured":"Ramalingam D, Happel C, Ziegelbauer JM . Kaposi's sarcoma-associated herpesvirus microRNAs repress breakpoint cluster region protein expression, enhance Rac1 activity, and increase in vitro angiogenesis. J Virol 2015; 89: 4249\u20134261.","journal-title":"J Virol"},{"key":"BFonc2017139_CR61","doi-asserted-by":"publisher","first-page":"e65","DOI":"10.1371\/journal.ppat.0030065","volume":"3","author":"MA Samols","year":"2007","unstructured":"Samols MA, Skalsky RL, Maldonado AM, Riva A, Lopez MC, Baker HV et al. Identification of cellular genes targeted by KSHV-encoded microRNAs. PLoS Pathog 2007; 3: e65.","journal-title":"PLoS Pathog"},{"key":"BFonc2017139_CR62","doi-asserted-by":"publisher","first-page":"14308","DOI":"10.1074\/jbc.M010202200","volume":"276","author":"N Atabey","year":"2001","unstructured":"Atabey N, Gao Y, Yao ZJ, Breckenridge D, Soon L, Soriano JV et al. Potent blockade of hepatocyte growth factor-stimulated cell motility, matrix invasion and branching morphogenesis by antagonists of Grb2 Src homology 2 domain interactions. J Biol Chem 2001; 276: 14308\u201314314.","journal-title":"J Biol Chem"},{"key":"BFonc2017139_CR63","doi-asserted-by":"publisher","first-page":"1709","DOI":"10.1091\/mbc.11.5.1709","volume":"11","author":"I Royal","year":"2000","unstructured":"Royal I, Lamarche-Vane N, Lamorte L, Kaibuchi K, Park M . Activation of cdc42, rac, PAK, and rho-kinase in response to hepatocyte growth factor differentially regulates epithelial cell colony spreading and dissociation. Mol Biol Cell 2000; 11: 1709\u20131725.","journal-title":"Mol Biol Cell"},{"key":"BFonc2017139_CR64","doi-asserted-by":"publisher","first-page":"5148","DOI":"10.1073\/pnas.1102033108","volume":"108","author":"HR Lin","year":"2011","unstructured":"Lin HR, Ganem D . Viral microRNA target allows insight into the role of translation in governing microRNA target accessibility. Proc Natl Acad Sci USA 2011; 108: 5148\u20135153.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFonc2017139_CR65","doi-asserted-by":"publisher","first-page":"9708","DOI":"10.1128\/JVI.01019-12","volume":"86","author":"KF Brulois","year":"2012","unstructured":"Brulois KF, Chang H, Lee AS, Ensser A, Wong LY, Toth Z et al. Construction and manipulation of a new Kaposi's sarcoma-associated herpesvirus bacterial artificial chromosome clone. J Virol 2012; 86: 9708\u20139720.","journal-title":"J Virol"},{"key":"BFonc2017139_CR66","doi-asserted-by":"publisher","first-page":"2514","DOI":"10.1161\/01.CIR.96.8.2514","volume":"96","author":"M Poon","year":"1997","unstructured":"Poon M, Zhang X, Dunsky KG, Taubman MB, Harpel PC . Apolipoprotein(a) induces monocyte chemotactic activity in human vascular endothelial cells. Circulation 1997; 96: 2514\u20132519.","journal-title":"Circulation"},{"key":"BFonc2017139_CR67","doi-asserted-by":"publisher","first-page":"1986","DOI":"10.1038\/onc.2013.136","volume":"33","author":"X Zhu","year":"2014","unstructured":"Zhu X, Guo Y, Yao S, Yan Q, Xue M, Hao T et al. Synergy between Kaposi's sarcoma-associated herpesvirus (KSHV) vIL-6 and HIV-1 Nef protein in promotion of angiogenesis and oncogenesis: role of the AKT signaling pathway. Oncogene 2014; 33: 1986\u20131996.","journal-title":"Oncogene"},{"key":"BFonc2017139_CR68","doi-asserted-by":"publisher","first-page":"e53145","DOI":"10.1371\/journal.pone.0053145","volume":"8","author":"F Zhou","year":"2013","unstructured":"Zhou F, Xue M, Qin D, Zhu X, Wang C, Zhu J et al. HIV-1 Tat promotes Kaposi's sarcoma-associated herpesvirus (KSHV) vIL-6-induced angiogenesis and tumorigenesis by regulating PI3K\/PTEN\/AKT\/GSK-3beta signaling pathway. PLoS One 2013; 8: e53145.","journal-title":"PLoS One"},{"key":"BFonc2017139_CR69","doi-asserted-by":"publisher","first-page":"4987","DOI":"10.1128\/JVI.00025-14","volume":"88","author":"Q Yan","year":"2014","unstructured":"Yan Q, Ma X, Shen C, Cao X, Feng N, Qin D et al. Inhibition of Kaposi's sarcoma-associated herpesvirus lytic replication by HIV-1 Nef and cellular microRNA hsa-miR-1258. J Virol 2014; 88: 4987\u20135000.","journal-title":"J Virol"},{"key":"BFonc2017139_CR70","doi-asserted-by":"publisher","first-page":"2401","DOI":"10.1128\/JVI.02024-06","volume":"81","author":"Y Zeng","year":"2007","unstructured":"Zeng Y, Zhang X, Huang Z, Cheng L, Yao S, Qin D et al. Intracellular Tat of human immunodeficiency virus type 1 activates lytic cycle replication of Kaposi's sarcoma-associated herpesvirus: role of JAK\/STAT signaling. J Virol 2007; 81: 2401\u20132417.","journal-title":"J Virol"},{"key":"BFonc2017139_CR71","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1111\/j.1462-5822.2007.01079.x","volume":"10","author":"D Qin","year":"2008","unstructured":"Qin D, Zeng Y, Qian C, Huang Z, Lv Z, Cheng L et al. Induction of lytic cycle replication of Kaposi's sarcoma-associated herpesvirus by herpes simplex virus type 1: involvement of IL-10 and IL-4. Cell Microbiol 2008; 10: 713\u2013728.","journal-title":"Cell Microbiol"},{"key":"BFonc2017139_CR72","doi-asserted-by":"publisher","first-page":"E54","DOI":"10.3390\/v8020054","volume":"8","author":"V Jain","year":"2016","unstructured":"Jain V, Plaisance-Bonstaff K, Sangani R, Lanier C, Dolce A, Hu J et al. A toolbox for herpesvirus miRNA research: construction of a complete set of KSHV miRNA deletion mutants. Viruses 2016; 8: pii: E54.","journal-title":"Viruses"},{"key":"BFonc2017139_CR73","doi-asserted-by":"publisher","first-page":"9862","DOI":"10.1093\/nar\/gku583","volume":"42","author":"M Xue","year":"2014","unstructured":"Xue M, Yao S, Hu M, Li W, Hao T, Zhou F et al. HIV-1 Nef and KSHV oncogene K1 synergistically promote angiogenesis by inducing cellular miR-718 to regulate the PTEN\/AKT\/mTOR signaling pathway. Nucleic Acids Res 2014; 42: 9862\u20139879.","journal-title":"Nucleic Acids Res"},{"key":"BFonc2017139_CR74","doi-asserted-by":"publisher","first-page":"9362","DOI":"10.1093\/nar\/gkv988","volume":"43","author":"S Yao","year":"2015","unstructured":"Yao S, Hu M, Hao T, Li W, Xue X, Xue M et al. MiRNA-891a-5p mediates HIV-1 Tat and KSHV Orf-K1 synergistic induction of angiogenesis by activating NF-kappaB signaling. Nucleic Acids Res 2015; 43: 9362\u20139378.","journal-title":"Nucleic Acids Res"}],"updated-by":[{"DOI":"10.1038\/s41388-021-01823-4","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2021,5,6]],"date-time":"2021-05-06T00:00:00Z","timestamp":1620259200000}}],"container-title":["Oncogene"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/onc2017139.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/onc2017139","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/doifinder\/10.1038\/onc.2017.139","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/www.nature.com\/articles\/onc2017139.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,21]],"date-time":"2022-03-21T16:25:19Z","timestamp":1647879919000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/onc2017139"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5,22]]},"references-count":74,"journal-issue":{"issue":"38","published-print":{"date-parts":[[2017,9,21]]}},"alternative-id":["BFonc2017139"],"URL":"https:\/\/doi.org\/10.1038\/onc.2017.139","relation":{},"ISSN":["0950-9232","1476-5594"],"issn-type":[{"value":"0950-9232","type":"print"},{"value":"1476-5594","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,5,22]]},"assertion":[{"value":"26 December 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 March 2017","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 March 2017","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 May 2017","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 May 2021","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1038\/s41388-021-01823-4","URL":"https:\/\/doi.org\/10.1038\/s41388-021-01823-4","order":8,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}